Vicarious Surgical (RBOT) Capital Leases (2022 - 2023)
Vicarious Surgical (RBOT) posted quarterly Capital Leases of $14.3 million for Q2 2023, down 6.32% year-over-year from $15.3 million in Q2 2022, and down 1.8% quarter-over-quarter from $14.6 million in Q1 2023.
Vicarious Surgical (RBOT) Capital Leases (2022 - 2023) Analysis & Trends
Vicarious Surgical (RBOT) has reported Capital Leases for 2 consecutive years, with $14.3 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Capital Leases fell 6.32% year-over-year to $14.3 million; the TTM figure through Jun 2023 stood at $14.3 million (down 6.32% YoY), while the FY2022 annual figure was $14.8 million, changed N/A from the prior year.
- Capital Leases fell to $14.3 million in Q2 2023 per RBOT's latest filing, from $14.6 million in the prior quarter.
- Across five years, Capital Leases topped out at $15.5 million in Q1 2022 and bottomed at $14.3 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 14.33 Mn |
| Mar 31, 2023 | 14.59 Mn |
| Dec 31, 2022 | 14.83 Mn |
| Sep 30, 2022 | 15.07 Mn |
| Jun 30, 2022 | 15.30 Mn |
| Mar 31, 2022 | 15.52 Mn |